Microbot Medical announces that it entered into a Phase 2 collaboration agreement with Corewell Health that will continue their collaboration to advance remote telesurgery for endovascular procedures. The Company had previously announced positive results from the first phase, which demonstrated LIBERTY’s technical capabilities and outlined potential future applications in a range of endovascular interventions, including the feasibility of LIBERTY to support the remote telesurgery project. During Phase 2, the Company and Corewell Health will work together to develop the capabilities to perform simulated cardiovascular interventional procedures with LIBERTY across two sites within the Corewell Health system which are 5 miles apart.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBOT:
- Microbot Medical Nears Global Compliance, Eyes Future Goals
- Microbot receives certification to support future regulatory submissions
- Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
- Microbot Medical: Pioneering Robotic Surgery with Emory University
- Microbot Medical, Emory University to evaluate future autonomous capabilities